Persona
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $6.5M | 5,413 | 1,793 |
| 2023 | $83.8M | 3,817 | 1,471 |
| 2022 | $25.2M | 3,716 | 1,258 |
| 2021 | $20.7M | 1,769 | 831 |
| 2020 | $18.5M | 1,145 | 389 |
| 2019 | $19.2M | 2,997 | 953 |
| 2018 | $17.1M | 3,526 | 1,231 |
| 2017 | $14.1M | 3,059 | 1,322 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $191.4M | 925 | 93.3% |
| Consulting Fee | $5.2M | 2,230 | 2.5% |
| Unspecified | $4.3M | 1,240 | 2.1% |
| Education | $1.5M | 1,339 | 0.7% |
| Food and Beverage | $1.2M | 14,840 | 0.6% |
| Travel and Lodging | $1.1M | 4,787 | 0.5% |
| Space rental or facility fees (teaching hospital only) | $297,362 | 53 | 0.1% |
| Gift | $171,036 | 20 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,000 | 2 | 0.0% |
| Long term medical supply or device loan | $76.05 | 6 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Persona OsseoTi Keel Compatibility Study – A Multicenter Cohort Study A prospective, post-market clinical follow-up study to demonstrate safety, performance and clinical benefits of the Persona Knee System Portfolio and its Instrumentation | Zimmer Biomet Holdings, Inc. | $631,287 | 0 |
| Persona Ti-Nidium Personalized Total Knee System | Zimmer Biomet Holdings, Inc. | $448,980 | 0 |
| Persona Partial Knee Clinical Outcomes Study | Zimmer Biomet Holdings, Inc. | $417,685 | 3 |
| Clinical Investigation to Demonstrate Performance, Safety, and Clinical Benefits of the Persona Revision Knee System | Zimmer Biomet Holdings, Inc. | $410,920 | 0 |
| Persona Personalized Knee System | Zimmer Biomet Holdings, Inc. | $323,614 | 1 |
| Randomized Controlled Trial to Compare Persona OsseoTi 0 Spiked Keel Cementless TKA vs Persona 0 Keel Cemented TKA | Zimmer Biomet Holdings, Inc. | $310,347 | 0 |
| CSU2014-02K PERSONA TKA Outcomes Study | Zimmer Biomet Holdings, Inc. | $270,150 | 1 |
| Persona TM Tibia Clinical Outcomes Study | Zimmer Biomet Holdings, Inc. | $247,362 | 1 |
| Sporer, Scott, K.CR.E.AM.15.2, Persona RSA | Zimmer Biomet Holdings, Inc. | $159,388 | 0 |
| POLAR TKA | Zimmer Biomet Holdings, Inc. | $134,190 | 0 |
| Clinical Investigation to Demonstrate Performance and Safety of the Persona Revision Knee System A Retrospective and Prospective Consecutive Series Study to Gain CE Approval | Zimmer Biomet Holdings, Inc. | $128,663 | 0 |
| CSU2014-02K, PERSONA TKA Outcomes Study | Zimmer Biomet Holdings, Inc. | $124,040 | 1 |
| Clinical Investigation to Demonstrate Performance and Safety of the Persona Revision Knee System – A Retrospective and Prospective Consecutive Series Study to Gain CE Approval | Zimmer Biomet Holdings, Inc. | $100,567 | 0 |
| Does Kinematically-Aligning the Persona Knee with Generic Instruments restore Five Envelopes of Passive Motion and Two Rotational Axes to Normal | Zimmer Biomet Holdings, Inc. | $95,194 | 0 |
| Persona RSA | Zimmer Biomet Holdings, Inc. | $90,883 | 0 |
| Randomized Controlled Trial to Compare Persona OsseoTi Keel Cementless TKA vs Persona Keel Cemented TKA | Zimmer Biomet Holdings, Inc. | $76,930 | 0 |
| IRU2016-101K Kinematic Analysis | Zimmer Biomet Holdings, Inc. | $51,924 | 0 |
| Persona OsseoTi Keel Compatibility Study – A Multicenter Cohort Study | Zimmer Biomet Holdings, Inc. | $33,686 | 0 |
| Persona IQ Remote Therapeutic Monitoring Pilot | Zimmer Biomet Holdings, Inc. | $29,227 | 0 |
| PIQ_1-Yr_Cohort | Zimmer Biomet Holdings, Inc. | $28,727 | 0 |
Top Doctors Receiving Payments for Persona
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Adult Reconstructive Orthopaedic Surgery | Philadelphia, PA | $17.4M | 61 |
| , M.D | Orthopaedic Surgery | Chicago, IL | $14.3M | 52 |
| , MD | Orthopaedic Surgery | Salt Lake City, UT | $12.6M | 30 |
| , M.D | Orthopaedic Surgery | Garden City, NY | $11.9M | 192 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Winfield, IL | $11.4M | 343 |
| , MD | Orthopaedic Surgery | Hackensack, NJ | $11.1M | 116 |
| , M.D | Orthopaedic Surgery | Los Angeles, CA | $11.0M | 35 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Columbus, OH | $11.0M | 32 |
| , MD | Orthopaedic Surgery | Paramus, NJ | $10.9M | 51 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Salt Lake City, UT | $9.9M | 29 |
| , M.D | Orthopaedic Surgery | Rochester, MN | $8.7M | 35 |
| , MD | Orthopaedic Surgery | Boise, ID | $8.2M | 59 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Omaha, NE | $7.6M | 390 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Philadelphia, PA | $7.3M | 76 |
| , MD | Orthopaedic Surgery | Seattle, WA | $7.3M | 32 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Tampa, FL | $7.3M | 148 |
| Unknown | — | Royal Oak, MI | $5.5M | 1,398 |
| , MD | Orthopaedic Surgery | New Albany, OH | $3.8M | 168 |
| , M.D | Orthopaedic Surgery | Beverly Hills, CA | $2.2M | 50 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Little Rock, AR | $2.1M | 25 |
| William Maloney | Orthopaedic Surgery | Redwood City, CA | $2.0M | 24 |
| , MD | Orthopaedic Surgery | Fort Worth, TX | $1.9M | 32 |
| , M.D | Orthopaedic Surgery | Houston, TX | $1.9M | 26 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Salt Lake City, UT | $1.7M | 48 |
| , MD | Orthopaedic Surgery | Weston, MA | $1.7M | 226 |
Manufacturing Companies
- Zimmer Biomet Holdings, Inc. $205.1M
Product Information
- Type Device
- Total Payments $205.1M
- Total Doctors 5,965
- Transactions 25,442
About Persona
Persona is a device associated with $205.1M in payments to 5,965 healthcare providers, recorded across 25,442 transactions in the CMS Open Payments database. The primary manufacturer is Zimmer Biomet Holdings, Inc..
Payment data is available from 2017 to 2024. In 2024, $6.5M was paid across 5,413 transactions to 1,793 doctors.
The most common payment nature for Persona is "Royalty or License" ($191.4M, 93.3% of total).
Persona is associated with 20 research studies, including "Persona OsseoTi Keel Compatibility Study – A Multicenter Cohort Study A prospective, post-market clinical follow-up study to demonstrate safety, performance and clinical benefits of the Persona Knee System Portfolio and its Instrumentation" ($631,287).